Jan Trofast
VP of Patent Strategy
AntiBioTX
Denmark
Biography
Jan Trofast is the co-inventor of Symbicort (annual >4 Billion USD) and the strategist behind a highly successful patent portfolio of 25+ patents protecting Symbicort and related products. Symbicort is expected to become AstraZeneca’s best selling drug - despite core patent expiration. Jan Trofast has more than 30 years of experience from AstraZeneca including a number of years with evaluation of internal and external projects. Jan Trofast obtained a Ph.D. in Organic Chemistry in 1978 and is the author of a significant scientific literature including several publications related to Jacob Berzelius. For his contributions he has been rewarded the Berzelius medal in gold by the Royal Swedish Academy of Sciences in 2001 and the Swedish Medicinal Chemistry Award by the Swedish Pharmaceutical Society in 2010.
Research Interest
Organic Chemistry
